Survey of hepatitis B viral markers at a public day school and a residential institution sharing mentally handicapped students

J Infect Dis. 1984 May;149(5):796-800. doi: 10.1093/infdis/149.5.796.

Abstract

The prevalence of hepatitis B virus markers was studied among employees and clients at a nonresidential public school for the mentally handicapped and at a privately operated residential facility. In the residential institution, 73 (80%) of 91 clients and 15 (16%) of 92 workers had positive tests for hepatitis B virus markers. Twenty-three clients, including six carriers of hepatitis B surface antigen (subtype ayw), received their education their education at the public school. Only two students (4%) who did not live at the residential institution and one employee (2%) had positive tests for hepatitis B virus markers. One of these students had acute hepatitis B infection, with hepatitis B surface antigen subtype ayw; the subtyping suggested that he had acquired the infection from one of the six carriers from the residential institution. Testing for IgM antibody to hepatitis B core antigen in single serum samples facilitated the identification of acute and chronic hepatitis B infection in children and staff of both facilities. The results show hepatitis B can be transmitted in this setting, and vaccination may be warranted for susceptible students and staff.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Animals
  • Carrier State
  • Child
  • Education of Intellectually Disabled*
  • Female
  • Hepatitis B / epidemiology
  • Hepatitis B / transmission
  • Hepatitis B Antibodies / analysis*
  • Hepatitis B Core Antigens / analysis
  • Hepatitis B Surface Antigens / analysis*
  • Hepatitis B e Antigens / analysis
  • Humans
  • Immunoglobulin M / analysis
  • Intellectual Disability*
  • Male
  • Residential Facilities*
  • Schools*

Substances

  • Hepatitis B Antibodies
  • Hepatitis B Core Antigens
  • Hepatitis B Surface Antigens
  • Hepatitis B e Antigens
  • Immunoglobulin M